SKU: TI18≥ 99% HPLC
Tesa-Ipa
Research Compound · Research use only

Tesa-IpaTesa-Ipa is a two-component laboratory blend supplied in a single vial containing GHRH-T 12mg and Ipamorelin 6mg. GHRH-T is a synthetic analog of human GHRH(1-44) bearing an N-terminal hexenoyl modification studied for the resistance it confers to enzymatic cleavage; Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the GHS-R1a (ghrelin) receptor. Because the two peptides bind unrelated receptor families, the blend is supplied as a paired reference material for in vitro receptor-binding and receptor-selectivity panels, cAMP and calcium-flux assays in transfected cell lines, and chromatographic separation, identity, and purity work by HPLC and LC-MS/MS. For research and laboratory use only; not for human or animal consumption.

$161.99/ vial · 18mg
In stock
Est. Arrival: 11/25/2026Ships today if ordered by 4PM EST
Select Size
Volume Discounts
1
Purity
99%+
Form
Lyophilized Powder
Quantity
18 mg
Storage
Store lyophilized at -20 °C, sealed, away from light and moisture
Batch / Lot
202612-01-TI
99%+ PurityHPLC · third-party
COA Includedlot 202609-01-TI
USA BasedMidwest Region
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
$161.99Tesa-Ipa · 18mg × 1

Product Details

Tesa-Ipa is a laboratory blend of two structurally distinct synthetic peptides, GHRH-T and Ipamorelin, supplied together in a single vial for comparative in vitro work across two separate receptor targets.


GHRH-T is a synthetic analog of human GHRH(1-44) modified with an N-terminal hexenoyl group. That modification is the subject of serum-stability and degradation assays, where it is studied for the resistance it confers to enzymatic cleavage relative to the unmodified sequence. In receptor pharmacology GHRH-T is characterized as an agonist at the GHRH receptor, a class B G-protein-coupled receptor, and is used in vitro as a ligand for GHRH-receptor binding affinity measurements and cAMP accumulation assays in transfected cell lines.


Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the ghrelin receptor GHS-R1a. In comparative in vitro binding panels it is noted for selectivity toward GHS-R1a over other pituitary-expressed receptor targets, which makes it a useful reference ligand when profiling receptor cross-reactivity and assay specificity.


Because the two peptides engage unrelated receptor families, the blend is used in laboratory settings as a paired reference material for receptor-selectivity panels, radioligand and fluorescence-polarization binding assays, calcium-flux and cAMP readouts, and reversed-phase HPLC or LC-MS/MS separation, identity confirmation, and purity determination of the two components.


GHRH-T: 12mg

Ipamorelin: 6mg


Disclaimer: Tesa-Ipa is supplied strictly for research and laboratory use only. This product is not a drug, dietary supplement, or medical device. It is not intended for human or animal consumption, and not for therapeutic, diagnostic, or clinical application. All handling should be performed by qualified researchers in accordance with applicable laboratory safety protocols and institutional guidelines.

Frequently Asked Questions About Tesa-Ipa

Answers summarize published research and are provided for laboratory research purposes only.

Tesa-Ipa is a two component laboratory blend supplied in a single vial containing GHRH-T 12mg and Ipamorelin 6mg. GHRH-T is a synthetic analog of human GHRH(1-44) with an N-terminal hexenoyl modification, and Ipamorelin is a synthetic pentapeptide characterized as a selective GHS-R1a agonist. Because the two peptides act on unrelated receptor families, research studies have used the Tesa-Ipa blend as a paired reference material for receptor selectivity panels and chromatographic identity and purity work.
In receptor pharmacology research, the GHRH-T in Tesa-Ipa has been characterized as an agonist at the GHRH receptor, a class B G-protein coupled receptor, and researchers have used it in cAMP accumulation assays in transfected cell lines. The Ipamorelin in Tesa-Ipa has been characterized in research studies as a selective agonist at the ghrelin receptor GHS-R1a. In vitro binding panels have noted its selectivity for GHS-R1a over other pituitary expressed receptors.
The primary research use of Tesa-Ipa is comparative in vitro receptor work. Researchers have used the blend as a paired ligand set in radioligand and fluorescence polarization binding assays, calcium flux readouts, and cAMP assays, where one component engages the GHRH receptor and the other engages GHS-R1a. Having both peptides in one vial allows a laboratory to profile receptor cross reactivity and assay specificity using two structurally distinct compounds from the same lot.
A second research area for Tesa-Ipa is analytical chemistry. Because GHRH-T is a 44 amino acid peptide and Ipamorelin is a pentapeptide, the blend is used for reversed phase HPLC and LC-MS/MS method development, where the two components separate cleanly and serve as identity and purity markers. The hexenoyl modification on GHRH-T is also studied in serum stability assays, where researchers have reported that it confers resistance to enzymatic cleavage compared with the unmodified GHRH sequence.
Evidence for the Tesa-Ipa components comes from separate literatures. GHRH-T has been studied in cell based receptor assays, animal models, and human clinical trials as a GHRH analog. Ipamorelin has been characterized in vitro and in animal models as a selective growth hormone secretagogue. The Tesa-Ipa blend itself is a laboratory reference material and has not been the subject of its own clinical trials. It is supplied by Biotech Compounds for in vitro and analytical research only.
Both blends pair a GHRH receptor ligand with the GHS-R1a agonist Ipamorelin, but the GHRH component differs. Tesa-Ipa uses GHRH-T, the full 44 amino acid GHRH sequence with an N-terminal hexenoyl group that research studies have reported resists aminopeptidase cleavage. The Ipamorelin and CJC-1295 no DAC blend uses a modified 29 amino acid GHRH fragment instead. Researchers comparing full length and truncated GHRH analogs against the same ghrelin receptor ligand can run the two blends side by side.
Yes. Tesa-Ipa from Biotech Compounds is listed at 99 percent or higher purity and each lot is tested by an independent laboratory. The Certificate of Analysis for Tesa-Ipa is posted on the product page and reports identity and purity for both the GHRH-T and Ipamorelin components of that batch. Researchers should match the lot number on the Tesa-Ipa vial to the posted COA before starting work.

Purity, documented